A randomized phase I study of methanesulfonyl fluoride, an irreversible cholinesterase inhibitor, for the treatment of Alzheimer's disease
Moss, Donald E., Fariello, Ruggero G., Sahlmann, Jörg, Sumaya, Isabel, Pericle, Federica, Braglia, EnricoVolume:
75
Language:
english
Journal:
British Journal of Clinical Pharmacology
DOI:
10.1111/bcp.12018
Date:
May, 2013
File:
PDF, 1.65 MB
english, 2013